Biotechnology
-
ADC Bio Completes Cleanroom Facility
8-10-2019ADC Bio completed construction of a £5 million bioconjugation cleanroom in July of 2019.
-
Designing Academic Research Facilities for the Fourth Industrial Revolution
7-17-2019The term “Fourth Industrial Revolution” (4IR) was coined in 2016 by Klaus Schwab, founder and executive chairman of the World Economic Forum, to describe the exponential transformation society and commerce are experiencing due to converging breakthroughs in numerous fields, such as artificial intelligence, robotics, 3D printing, nanotechnology, biotechnology, materials science, energy storage, the internet of things (IoT), and quantum computing. While this latest advancement is to some degree an extension of the third revolution (aka: The Digital Revolution), 4IR is considered a new era because of the unprecedented speed, scope, and systems impact of the coming changes. It is evolving at an exponential rate rather than a linear one and is expected to disrupt entire systems of production, management, transportation, and governance on a global scale. In response, a new breed of interdisciplinary research facility is emerging, as academic institutions try to anticipate training students for the unforeseen demands of the 4IR.
-
ElevateBio Designs Waltham cGMP Development and Manufacturing Facility
7-13-2019ElevateBio has selected DPS Group and TRIA to design ElevateBio BaseCamp, a 108,000-sf cGMP development and manufacturing facility in Waltham.
-
Aldevron Plans Fargo Biologics Campus
6-20-2019Aldevron will begin construction in August of 2019 on a 14-acre biologics campus in Fargo, N.D., where it is currently headquartered. The first phase comprises a two-story, 189,000-sf facility for the manufacture of plasmid DNA, proteins, mRNA, and antibodies.
-
The Wistar Institute and University Place Associates Plan Philadelphia Research and Discovery Hub
6-18-2019The Wistar Institute is partnering with University Place Associates to construct a 240,000-sf life science discovery hub in the University City district of Philadelphia.
-
WuXi Biologics Constructs Dundalk Single-Use Production Facility
6-15-2019WuXi Biologics began construction in May of 2019 on a $365 million pharmaceutical production facility in Dundalk, Ireland.
-
Iovance Biotherapeutics Plans Production Facility at Philadelphia Navy Yard
6-11-2019Iovance Biotherapeutics entered into a lease agreement in May of 2019 to construct a 136,000-sf facility at the Philadelphia Navy Yard.
-
Chugai Pharmaceuticals Builds Yokohama R&D Center
6-5-2019Chugai Pharmaceuticals will begin construction in August of 2019 on a $1.15 billion research and development center in Yokohama, Japan.
-
WuXi Biologics Constructs Integrated Manufacturing Center In Chengdu
6-2-2019WuXi Biologics began construction in May of 2019 on a 1.3 million-sf integrated manufacturing center in Chengdu, China. Meeting the criteria of both the U.S.
-
Bayer Breaks Ground on Cell Culture Technology Center
5-22-2019Bayer broke ground in May of 2019 on the $150 million Cell Culture Technology Center in Berkeley, Calif.
